|
Volumn 4, Issue 4, 2007, Pages 277-283
|
National guidelines for post-exposure prophylaxis after non-occupational exposure to HIV
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DIDANOSINE;
EFAVIRENZ;
EMTRICITABINE;
LAMIVUDINE;
LOPINAVIR PLUS RITONAVIR;
NEVIRAPINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STAVUDINE;
TENOFOVIR;
ZIDOVUDINE;
ANUS INTERCOURSE;
ANXIETY;
DRUG CONTRAINDICATION;
DRUG SAFETY;
EXPOSURE;
FEAR;
FOLLOW UP;
HEALTH EDUCATION;
HEPATITIS B;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE;
INFECTION PREVENTION;
INFECTION RISK;
LABORATORY TEST;
MALE HOMOSEXUAL;
PRACTICE GUIDELINE;
PREGNANCY;
PRISONER;
PROSTITUTION;
REVIEW;
RISK ASSESSMENT;
SEROPREVALENCE;
SEXUAL CRIME;
SEXUAL INTERCOURSE;
SEXUALLY TRANSMITTED DISEASE;
TETANUS;
TREATMENT DURATION;
VERTICAL TRANSMISSION;
VIRUS TRANSMISSION;
ANTI-HIV AGENTS;
AUSTRALIA;
HEALTH POLICY;
HIV INFECTIONS;
HUMANS;
MEDICAL HISTORY TAKING;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES AS TOPIC;
RISK ASSESSMENT;
SEXUALLY TRANSMITTED DISEASES, VIRAL;
SUBSTANCE ABUSE, INTRAVENOUS;
|
EID: 36349003452
PISSN: 14485028
EISSN: None
Source Type: Journal
DOI: 10.1071/SH07067 Document Type: Review |
Times cited : (8)
|
References (0)
|